Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; Pharmacotherapy Education and Research Center, School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Tex; College of Pharmacy, The University of Texas at Austin, Austin, Tex.
Veterans Administration Research Center for AIDS and HIV-1 Infection and Center for Personalized Medicine, South Texas Veterans Health Care System, San Antonio, Tex; South Texas Veterans Health Care System, San Antonio, Tex; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Tex.
J Allergy Clin Immunol. 2021 Nov;148(5):1176-1191. doi: 10.1016/j.jaci.2021.08.021. Epub 2021 Sep 8.
The risk of severe coronavirus disease 2019 (COVID-19) varies significantly among persons of similar age and is higher in males. Age-independent, sex-biased differences in susceptibility to severe COVID-19 may be ascribable to deficits in a sexually dimorphic protective attribute that we termed immunologic resilience (IR).
We sought to examine whether deficits in IR that antedate or are induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection independently predict COVID-19 mortality.
IR levels were quantified with 2 novel metrics: immune health grades (IHG-I [best] to IHG-IV) to gauge CD8 and CD4 T-cell count equilibrium, and blood gene expression signatures. IR metrics were examined in a prospective COVID-19 cohort (n = 522); primary outcome was 30-day mortality. Associations of IR metrics with outcomes in non-COVID-19 cohorts (n = 13,461) provided the framework for linking pre-COVID-19 IR status to IR during COVID-19, as well as to COVID-19 outcomes.
IHG-I, tracking high-grade equilibrium between CD8 and CD4 T-cell counts, was the most common grade (73%) among healthy adults, particularly in females. SARS-CoV-2 infection was associated with underrepresentation of IHG-I (21%) versus overrepresentation (77%) of IHG-II or IHG-IV, especially in males versus females (P < .01). Presentation with IHG-I was associated with 88% lower mortality, after controlling for age and sex; reduced risk of hospitalization and respiratory failure; lower plasma IL-6 levels; rapid clearance of nasopharyngeal SARS-CoV-2 burden; and gene expression signatures correlating with survival that signify immunocompetence and controlled inflammation. In non-COVID-19 cohorts, IR-preserving metrics were associated with resistance to progressive influenza or HIV infection, as well as lower 9-year mortality in the Framingham Heart Study, especially in females.
Preservation of immunocompetence with controlled inflammation during antigenic challenges is a hallmark of IR and associates with longevity and AIDS resistance. Independent of age, a male-biased proclivity to degrade IR before and/or during SARS-CoV-2 infection predisposes to severe COVID-19.
相似年龄的人患严重 2019 冠状病毒病(COVID-19)的风险差异很大,男性的风险更高。对严重 COVID-19 的易感性与年龄无关的性别差异可能归因于一种我们称之为免疫弹性(IR)的性别二态保护性特征的缺陷。
我们试图研究严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染前或感染后出现的 IR 缺陷是否独立预测 COVID-19 死亡率。
使用 2 种新的指标来量化 IR 水平:免疫健康等级(IHG-I[最佳]至 IHG-IV),以衡量 CD8 和 CD4 T 细胞计数平衡,以及血液基因表达特征。在一项前瞻性 COVID-19 队列研究(n=522)中检查了 IR 指标;主要结局是 30 天死亡率。在非 COVID-19 队列研究(n=13461)中,IR 指标与结局的相关性为 COVID-19 前的 IR 状态与 COVID-19 期间的 IR 以及 COVID-19 结局提供了框架。
在健康成年人中,IGH-I 最为常见(73%),它代表了 CD8 和 CD4 T 细胞计数之间高度平衡的状态,尤其是在女性中。SARS-CoV-2 感染与 IHG-I 代表率低(21%)与 IHG-II 或 IHG-IV 代表率高(77%)有关,尤其是在男性与女性之间(P<.01)。在控制年龄和性别后,IGH-I 的表现与死亡率降低 88%相关;住院和呼吸衰竭的风险降低;血浆白细胞介素-6 水平降低;鼻咽 SARS-CoV-2 负荷的快速清除;以及与生存相关的表明免疫能力和炎症控制的基因表达特征。在非 COVID-19 队列中,IR 保持指标与抵抗流感或 HIV 感染以及弗雷明汉心脏研究中 9 年死亡率降低有关,尤其是在女性中。
在抗原挑战期间保持免疫能力和炎症控制是 IR 的一个标志,与长寿和 AIDS 抵抗力有关。与年龄无关,男性在 SARS-CoV-2 感染前和/或感染期间存在的 IR 恶化倾向,易患严重 COVID-19。